Multi-agent System for Obtaining Relevant Genes in Expression Analysis between Young and Older Women with Triple Negative Breast Cancer

Summary Triple negative breast cancer is an aggressive form of breast cancer. Despite treatment with chemotherapy, relapses are frequent and response to these treatments is not the same in younger women as in older women. Therefore, the identification of genes that cause this difference is required. The identification of therapeutic targets is one of the sought after goals to develop new drugs. Within the range of different hybridization techniques, the developed system uses expression array analysis to measure the expression of the signal levels of thousands of genes in a given sample. Probesets of Gene 1.0 ST GeneChip arrays provide categorical genome transcript coverage, providing a measurement of the expression level of the sample. This paper proposes a multi-agent system to manage information of expression arrays, with the goal of providing an intuitive system that is also extensible to analyze and interpret the results. The roles of agent integrate different types of techniques, statistical and data mining methods that select a set of genes, searching techniques that find pathways in which such genes participate, and an information extraction procedure that applies a CBR system to check if these genes are involved in the disease.

[1]  Yee Wen Choon,et al.  Differential Bees Flux Balance Analysis with OptKnock for In Silico Microbial Strains Optimization , 2014, PloS one.

[2]  Irina Klaman,et al.  Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors. , 2004, International journal of oncology.

[3]  Tu-Bao Ho,et al.  Detecting disease genes based on semi-supervised learning and protein-protein interaction networks , 2012, Artif. Intell. Medicine.

[4]  S. Sizemore,et al.  GABA(A) Receptor Pi (GABRP) Stimulates Basal-like Breast Cancer Cell Migration through Activation of Extracellular-regulated Kinase 1/2 (ERK1/2)* , 2014, The Journal of Biological Chemistry.

[5]  Shi-Hua Zhang,et al.  Discovery of co-occurring driver pathways in cancer , 2014, BMC Bioinformatics.

[6]  Helmut Klocker,et al.  A hormone-dependent feedback-loop controls androgen receptor levels by limiting MID1, a novel translation enhancer and promoter of oncogenic signaling , 2014, Molecular Cancer.

[7]  K. Kinzler,et al.  Cancer genes and the pathways they control , 2004, Nature Medicine.

[8]  G. Robb,et al.  Advanced Therapy of Breast Disease , 1999 .

[9]  H. Lai,et al.  SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway , 2007, International journal of cancer.

[10]  R. Bast,et al.  Multivariable analysis of DNA ploidy, p53, and HER‐2/neu as prognostic factors in endometrial cancer , 1994, Cancer.

[11]  Estefania Argente,et al.  An abstract architecture for virtual organizations: The THOMAS approach , 2011, Knowledge and Information Systems.

[12]  See-Kiong Ng,et al.  InterDom: a database of putative interacting protein domains for validating predicted protein interactions and complexes , 2003, Nucleic Acids Res..

[13]  Javier Bajo,et al.  aCGH-MAS: Analysis of aCGH by means of Multiagent System , 2015, BioMed research international.

[14]  Christian Ruckert,et al.  Influence of secreted frizzled receptor protein 1 (SFRP1) on neoadjuvant chemotherapy in triple negative breast cancer does not rely on WNT signaling , 2014, Molecular Cancer.

[15]  B. Ylstra,et al.  BAC to the future! or oligonucleotides: a perspective for micro array comparative genomic hybridization (array CGH) , 2006, Nucleic acids research.

[16]  R. Tibshirani,et al.  A method for calling gains and losses in array CGH data. , 2005, Biostatistics.

[17]  Steen Knudsen Cancer Diagnostics with DNA Microarrays , 2006 .

[18]  Mark A. van de Wiel,et al.  Microarray Data Analysis: From Hypotheses to Conclusions Using Gene Expression Data , 2004, Cellular oncology : the official journal of the International Society for Cellular Oncology.

[19]  Gene Ontology Consortium The Gene Ontology (GO) database and informatics resource , 2003 .

[20]  E. Winzeler,et al.  Genomics, gene expression and DNA arrays , 2000, Nature.

[21]  B. Scheithauer,et al.  DNA microarrays , 2005, Endocrine.

[22]  Susumu Goto,et al.  Data, information, knowledge and principle: back to metabolism in KEGG , 2013, Nucleic Acids Res..

[23]  E. Birney,et al.  Reactome: a knowledgebase of biological pathways , 2004, Nucleic Acids Research.

[24]  David S. Wishart,et al.  DrugBank: a knowledgebase for drugs, drug actions and drug targets , 2007, Nucleic Acids Res..

[25]  Graziano Pesole,et al.  Selection of relevant genes in cancer diagnosis based on their prediction accuracy , 2007, Artif. Intell. Medicine.

[26]  Thierry Couffinhal,et al.  FrzA/sFRP-1, a secreted antagonist of the Wnt-Frizzled pathway, controls vascular cell proliferation in vitro and in vivo. , 2004, Cardiovascular research.

[27]  Javier Bajo,et al.  Model of experts for decision support in the diagnosis of leukemia patients , 2009, Artif. Intell. Medicine.

[28]  Yi Xing,et al.  Exon arrays provide accurate assessments of gene expression , 2007, Genome Biology.

[29]  D. Pinkel,et al.  Array comparative genomic hybridization and its applications in cancer , 2005, Nature Genetics.

[30]  Patrick G Buckley,et al.  Genomic microarrays in the spotlight. , 2004, Drug discovery today.

[31]  Robert D. Finn,et al.  The Pfam protein families database , 2004, Nucleic Acids Res..

[32]  Javier Bajo,et al.  MicroCBR: A case-based reasoning architecture for the classification of microarray data , 2011, Appl. Soft Comput..

[33]  中尾 光輝,et al.  KEGG(Kyoto Encyclopedia of Genes and Genomes)〔和文〕 (特集 ゲノム医学の現在と未来--基礎と臨床) -- (データベース) , 2000 .

[34]  E. Dermitzakis From gene expression to disease risk , 2008, Nature Genetics.